EISSN 2148-5607

TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.4

Turkish Journal of Gastroenterology

35 414 2024

Submission to First Decision = 31 Days

HIGHLY CITED ARTICLES

HBV and HCV are the risk factors in CCA

Tan et al.

Serum resolvin levels in irritable bowel syndrome

Karatay and Gül Utku

Microbial improvement after intervention

Qian et al.

18F-FDGPET/CT in gallbladder carcinoma

Arslan et al.

Bezoar in endoscopy

Gökbulut et al.

Effect of vitamin D on CD40L gene expression in UC

Sharifi et al.

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Editorial

Ursodeoxycholic acid can be used as a steroid-tapering drug in the treatment of autoimmune hepatitis

Rukiye VARDAR ¹ , Galip ERSÖZ ² , Zeki KARASU ³ , Ulus S. AKARCA ⁴ , Yücel BATUR ²

Author Affiliation(s)

1.

SSK İzmir Eğitim ve Araştırma Hastanesi Dahiliye Kliniği, İzmir

2.

Ege Üniversitesi Tıp Fakültesi Gastroenteroloji ve Mikrobiyoloji Anabilim Dalları, İzmir

3.

Ege Üniversitesi Tıp Fakültesi Gastroenteroloji Bilim Dalı, İzmir

4.

Ege Universitesi Tıp Fakültesi Gastroenteroloji Bilim Dalı

Turk J Gastroenterol 2001; 12: 249-252

Keywords : Autoimmune hepatitis, ursodeoxycholic acid.

Read: 1696 Downloads: 1488 Published: 25 July 2019

Volume 12, Issue 4, December 2001

Previous Article

Files